The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent late lumen loss at nine months in the results of an imaging substudy reported at EuroPCR 2013 today.
Fuente : http://www.eurekalert.org/pub_releases/2013-05/eso...
Fuente : http://www.eurekalert.org/pub_releases/2013-05/eso...